Virology category label.

COVID-19 Treatment Study

Monitoring and clinical assessments of COVID-19 patients from home

We are conducting an ongoing study with a specialty pharmaceutical company to test the efficacy and safety of a treatment for Covid-19. Studies to date conducted on treatments like remdesivir have focused on intravenous medications for hospitalized patients. Yet the majority of patients with COVID-19 are, fortunately, not being hospitalized. They are told to self-isolate, rest, and take symptomatic medications. This highlights a significant unmet medical need for an oral, easily administered medication for treatment of symptomatic COVID-19 patients at home. Until recently, it was assumed that patients needed to travel for certain types of research related assessments. However, inroads in the development of accurate and 510(k) cleared medical devices for in-home use enable patients in clinical trials to do much of this from home, opening up a world of opportunity for more convenient capture of real-world data.

Objective

Evaluate the safety and efficacy on non-hospitalized COVID-19 patients of an oral investigational drug.

Methodology

We are conducting a randomized, double-blind, placebo-controlled hybrid study. Participants were enrolled through a clinical site and sent home with the study drug and several devices to collect both telemetric information and patient-reported information in order to measure the safety and efficacy of the investigational treatment. Measurements include temperature, respiratory and pulse rates, blood pressure, pulse oximetry, electrocardiogram (ECG) and weight.

Home healthcare nurses are scheduled to perform four in-home visits to check-in on patients, collect blood samples for certain laboratory parameters, perform virus PCR swabs at home, and assist in certain patient-reported data capture, using devices provided to participants at home.

Results

While it is too soon to point to any results, an immediate benefit of this approach is the level of convenience provided to participants. By structuring the study for only a single initial site visit and then following with a combination of ePRO, device use and in-home visits, we minimize the disruption inpatients’ lives while cost effectively collecting high quality and reliable data.

Learn More About Our Virtual Clinical Studies Platform

Fill in the form below and our clinical operations team will be in touch.